Inventor · disambiguated record
Amy J. Johnson
Also filed as: JOHNSON AMY · JOHNSON AMY J · JOHNSON AMY JO
6 granted patents·11 pending applications·66 citations·filing 2011–2024
84Inventor score
Files withPHARMACYCLICS LLC11ANGST DANIELA1BYRD JOHN C1NOVARTIS AG1OHIO STATE INNOVATION FOUNDATION1
Top patents by PatentIndex Score
17 records- 0195US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 0294US10695350B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2019·Granted Jun 30, 2020·6 cites·8 claims
- 0393US9795604B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2014·Granted Oct 24, 2017·19 cites·55 claims
- 0491US10463668B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Granted Nov 5, 2019·8 cites·4 claims
- 0591US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 0688US2025345335A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 0785US2024293408A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 0879US2023097340A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 0971US2021121463A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1063US9044474B2Compositions and methods for increasing drug efficacy in cancerBYRD JOHN C·Filed 2011·Granted Jun 2, 2015·1 cites·10 claims
- 1162US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1262US2020147084A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1359US2014371241A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 1455US2018071293A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1540US2015361504A1Biomarker for predicting response of cll to treatment with a btk inhibitorPHARMACYCLICS LLC·Filed 2015·Application pending·0 cites
- 1635US2017298446A1Biomarkers of bruton tyrosine kinase inhibitor resistanceOHIO STATE INNOVATION FOUNDATION·Filed 2015·Application pending·0 cites
- 1733US2018140602A1Combination of chimeric antigen receptor therapy and amino pyrimidine derivativesANGST DANIELA·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →